118 related articles for article (PubMed ID: 24496501)
1. A tuned affinity-based staurosporine probe for in situ profiling of protein kinases.
Cheng X; Li L; Uttamchandani M; Yao SQ
Chem Commun (Camb); 2014 Mar; 50(22):2851-3. PubMed ID: 24496501
[TBL] [Abstract][Full Text] [Related]
2. Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe.
Shi H; Cheng X; Sze SK; Yao SQ
Chem Commun (Camb); 2011 Oct; 47(40):11306-8. PubMed ID: 21922114
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS).
Fischer JJ; Dalhoff C; Schrey AK; Graebner OY; Michaelis S; Andrich K; Glinski M; Kroll F; Sefkow M; Dreger M; Koester H
J Proteomics; 2011 Dec; 75(1):160-8. PubMed ID: 21664307
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling.
Li Z; Hao P; Li L; Tan CY; Cheng X; Chen GY; Sze SK; Shen HM; Yao SQ
Angew Chem Int Ed Engl; 2013 Aug; 52(33):8551-6. PubMed ID: 23754342
[No Abstract] [Full Text] [Related]
5. Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application.
Hirozane Y; Toyofuku M; Yogo T; Tanaka Y; Sameshima T; Miyahisa I; Yoshikawa M
Bioorg Med Chem Lett; 2019 Nov; 29(21):126641. PubMed ID: 31526603
[TBL] [Abstract][Full Text] [Related]
6. A fragment-based selection approach for the discovery of peptide macrocycles targeting protein kinases.
Restituyo E; Camacho-Soto K; Ghosh I
Methods Mol Biol; 2015; 1248():95-104. PubMed ID: 25616328
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the inhibitor recognition of human Lyn kinase domain.
Miyano N; Kinoshita T; Nakai R; Kirii Y; Yokota K; Tada T
Bioorg Med Chem Lett; 2009 Dec; 19(23):6557-60. PubMed ID: 19857964
[TBL] [Abstract][Full Text] [Related]
8. Systematic response of staurosporine scaffold-based inhibitors to drug-resistant cancer kinase mutations.
He Y
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900320. PubMed ID: 32285482
[TBL] [Abstract][Full Text] [Related]
9. Tethering small molecules to a phage display library: discovery of a selective bivalent inhibitor of protein kinase A.
Meyer SC; Shomin CD; Gaj T; Ghosh I
J Am Chem Soc; 2007 Nov; 129(45):13812-3. PubMed ID: 17944472
[No Abstract] [Full Text] [Related]
10. Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.
Shomin CD; Meyer SC; Ghosh I
Bioorg Med Chem; 2009 Sep; 17(17):6196-202. PubMed ID: 19674907
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
Kawaguchi M; Terai T; Utata R; Kato M; Tsuganezawa K; Tanaka A; Kojima H; Okabe T; Nagano T
Bioorg Med Chem Lett; 2008 Jul; 18(13):3752-5. PubMed ID: 18524589
[TBL] [Abstract][Full Text] [Related]
12. Functional interrogation of the kinome using nucleotide acyl phosphates.
Patricelli MP; Szardenings AK; Liyanage M; Nomanbhoy TK; Wu M; Weissig H; Aban A; Chun D; Tanner S; Kozarich JW
Biochemistry; 2007 Jan; 46(2):350-8. PubMed ID: 17209545
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase inhibition of clinically important staurosporine analogues.
Gani OA; Engh RA
Nat Prod Rep; 2010 Apr; 27(4):489-98. PubMed ID: 20336234
[TBL] [Abstract][Full Text] [Related]
14. Docking simulation study and kinase selectivity of f152A1 and its analogs.
Ikemori-Kawada M; Inoue A; Goto M; Wang YJ; Kawakami Y
J Chem Inf Model; 2012 Aug; 52(8):2059-68. PubMed ID: 22830536
[TBL] [Abstract][Full Text] [Related]
15. A priori inference of cross reactivity for drug-targeted kinases.
Fernandez A; Maddipati S
J Med Chem; 2006 Jun; 49(11):3092-100. PubMed ID: 16722629
[TBL] [Abstract][Full Text] [Related]
16. Proteome-wide identification of staurosporine-binding kinases using capture compound mass spectrometry.
Fischer JJ; Graebner Neé Baessler OY; Dreger M
Methods Mol Biol; 2012; 795():135-47. PubMed ID: 21960220
[TBL] [Abstract][Full Text] [Related]
17. Structure of human Fyn kinase domain complexed with staurosporine.
Kinoshita T; Matsubara M; Ishiguro H; Okita K; Tada T
Biochem Biophys Res Commun; 2006 Aug; 346(3):840-4. PubMed ID: 16782058
[TBL] [Abstract][Full Text] [Related]
18. On the origins of enzyme inhibitor selectivity and promiscuity: a case study of protein kinase binding to staurosporine.
Tanramluk D; Schreyer A; Pitt WR; Blundell TL
Chem Biol Drug Des; 2009 Jul; 74(1):16-24. PubMed ID: 19519740
[TBL] [Abstract][Full Text] [Related]
19. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
20. Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes.
Shi H; Zhang CJ; Chen GY; Yao SQ
J Am Chem Soc; 2012 Feb; 134(6):3001-14. PubMed ID: 22242683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
